chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Bleeding; Shortness of breath; Chest pain; Fever of 102; Viral myocarditis; This is a spontaneous report from a contactable consumer (parent). A 22-year-old male patient received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration assuming left arm, at age 22 years, on 05May2021 (Batch/Lot Number: EW0153) as 2ND DOSE, SINGLE for COVID-19 immunization. The patient's medical history was reported as no. Concomitant medications were not reported. Patient historically took first dose of BNT162B2 at age 22 years on 14Apr2021 for COVID-19 immunization. Reporter's son unfortunately appeared was hospitalized for adverse reaction (bleeding) and the physician told reporter to report this. Patient had has viral myocarditis of heart on an unspecified date on May2021 after he got his second dose on 05May2021. On 06May2021, patient started having symptoms of  shortness of breath, chest pain and fever of 102 (unit: unknown) after the second dose, so he went to emergency room. Then on Friday , 07May2021, he ended up with bleeding, so admission date is 07May2021 and he is still in the hospital at the time of reporting, they don't know how long. Patient also underwent lab test and procedure that includes laboratory test on May2021, 2 weeks before, patient was fine until the second dose.  The outcome of the events was unknown.
Migraines Light Headed/Dizzy Swollen Gland on right neck  Swelling on right side of face Rash on neck and chest Pain on Right side of face  Throbbing pain in Ear on right side
PT EXPERIENCE HEADACHE, CHILLS, SLIGHT FEVER, AND DIARRHEA AFTER RECEIVING BOOSTRIX SHOT.
Interstitial fibrosis in lungs; Cough started; Cough started and progressively got worse; This is a spontaneous report from a contactable healthcare professional (patient). A 62-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in left arm on 07May2021 at 12:30 (Batch/Lot Number: ER8736) (at the age of 62-years-old) as dose 1, single for COVID-19 immunisation. Medical history included pulmonary fibrosis, fibromyalgia, lyme disease, chronic fatigue, right bundle branch block (RBBB), hypertension (HTN), gastrooesophageal reflux disease with esophagitis, depression, anxiety (ANX), restless leg syndrome (RLS), asthma, overactive bladder (OAB), clinical hypothyroid, obstructive sleep apnea, notalgia paresthetica, dysesthesia, osteoarthritis, polymyalgia, Obsessive-compulsive disorder (OCD), penicillin allergy, latex allergy, adhesive tape allergy, soy allergy, egg allergy, allergy to cow's milk, food allergy (Corn, Sugarbeet, Wheat, Peanut butter) and had COVID-19 prior to vaccination. Concomitant medications included losartan; thyroid; ropinirole hydrochloride (REQUIP); celecoxib (CELEXA); bupropion hydrochloride (WELLBUTRIN XL); all taken for an unspecified indication, start and stop date were not reported; montelukast sodium (SINGULAIR), albuterol sulfate, budesonide, formoterol fumarate (SYMBICORT); all taken for asthma, start and stop date were not reported. The patient previously took allopurinol (ELAVIL), azithromycin (Z-PAK), gabapentin and experienced drug allergy. The patient did not received any other vaccines within 4 weeks prior to the COVID vaccine. On 10May2021, cough started and progressively got worse. Patient was on Symbicort INH and albuterol INH already for asthma. Patient was also taking Singulair. Patient was put on a tapering dose of prednisone 50 mg a day for 2 days, then 40 mg a day for 2 days, 30 mg for 2 days, 20 mg for 2 days, 10 mg for 2 days then stopped. Patient still have the cough. Chest x-rays on 10May2021, showed interstitial fibrosis in lungs. The patient received prednisone taper, Symbicort and albuterol as treatment for the events. The patient underwent nasal swab (COVID-19 test) on 27May2021 with negative result. Outcome of events was resolved with sequel (as reported).
Left arm where Pneumovax 23 was administered is swollen from injection site to antecubital area and inside front area of arm. The swollen area is hot to touch and red. On evening of the injection the swollen area was itchy-today no itching noticed.  I took Ibuprofen 200 mg for the inflammation which seems to be somewhat effective. The swelling and redness remain.
Tingling in hands and feet,slight swelling of tongue,funny taste in mouth,pain in right ear,Benadryl taken at home for 2 days after also tired , lightheaded and slight headache. Now Zyrtec daily .... itching and tingling occurs in various areas and continues today.
After 2 days, I had a 2" rash at the injection site. After 12 days, I developed a 6" red, itchy ring around my injection site, and a large rash directly below the ring.  It stayed for 2 days and did not grow in size, then disappeared.
Next dase experienced loss of mobility on left arm, fevers, loss of energy, and painful urination.   Called the doctor but the office was closed.   2 days ago painful urination resolved; cranberry juice helped.  Mobility in arm is back and pain around vaccine area reduced. Also, dizziness and fevers resolved. Energy is slowly coming back and fatigued easily.   Did not take any medication or tried any other treatment.   Recovery at 90%  Patient reports no problems after the first dose.
no adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED in a 20-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C21A) for COVID-19 vaccination.     Concurrent medical conditions included Shellfish allergy.   In 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Oct-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED. At the time of the report, EXPIRED PRODUCT ADMINISTERED had resolved. Not Provided.       For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Concomitant medications were provided by the reporter No Treatment information was provided by the reporter.   This case was linked to MOD-2021-385972, MOD-2021-385984 (Patient Link).
extreme soreness/pain at injection site; This is a spontaneous report from a contactable nurse.  A 65-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EH9899), intramuscular on the left arm on 22Dec2020 06:00 at single dose COVID-19 immunisation.  The patient medical history and concomitant medications were not reported.  The patient experienced extreme soreness/pain at injection site on 22Dec2020 09:00.  The patient received no treatment. The outcome of the events was recovered on Dec2020.
Dose administered @ 9:30 am, at 1 PM began with throat clearing and coughing with mild tightness, intermittently. By 1:30-1:45 pm nose and mouth became itchy.  I took 12.5 mg Benadryl and used my Xopenex ( rescue inhaler) x 2 puffs with effect.  Itching resolved first and residual inflammation in airway was gone by 3-3:30 pm. This reaction is familiar to me from when I received Allergy Immunotherapy a few years ago. I had my Epipen  and additional Benadryl. Did not need it.
No adverse effects reported; one M-M-R II dose was administered into deltoid; This spontaneous report was received from a pharmacist and refers to a female patient of unknown age. Information regarding the patient's pertinent medical history, concurrent conditions, concomitant and historical drugs, drug reactions and allergies was not provided.   On 02-MAY-2019, the patient was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II), 1 dosage form, intramuscular into deltoid (lot # and expiration date were not provided) for prophylaxis. No adverse effects were reported.
The pt was seen in the ER on 3/25/01 because of redness and swelling, warmth and erythema involving the lateral aspect of the arm near the shoulder. The erythema stretches about 15cm from the shoulder to the elbow. Treated with water soaks, elevate arm and proscribed Keflex. Diagnosed with Cellulitis of the arm. Antibiotics changed to Augmentin.
Patient was sitting in my office following vaccinations and his face went pale.  He then said he felt dizzy, became clammy, and his eyes rolled back in his head.  He passed out for approximately 5 seconds and woke complaining of headache, nausea, and seeing black.  Patient's feet were elevated, cool rags placed on forehead and neck.  After about 5 minutes patient reported he could see okay but his head was still hurting, he was nauseated, and felt really tired.  He was given a few sips of a cold cola and monitored.  After about 15-20 minutes the patient was back to normal skin color and his only complaints were mild headache and feeling tired.  He was alert and oriented x 3 upon discharge.  He was able to ambulate out of building supervised by his mother and was stable at discharge.
Patient developed COVID infection 48hrs after vaccination. Lost sense of smell/taste and this progressed to cough, fever, chest congestion, fatigue, body aches, headaches.
This spontaneous report as received from a company representative refers to a patient of unknown age. The patient was vaccinated with ZOSTAVAX. No other co-suspects were reported. No concomitant medications were reported. On an unknown date the patient experienced positive serologic test for herpes simplex 1 and Herpes Simplex 2. No treatment information was reported. The outcome of herpes simplex is unknown. The relatedness for herpes simplex is unknown for ZOSTAVAX. Additional information has been requested.
SWELLING IN BOTH CALVES; HEADACHE; TIREDNESS; SHORTNESS OF BREATH; This spontaneous report received from a patient concerned a 59 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included non smoker, and non alcohol user, and other pre-existing medical conditions included the patient had no known drug allergies. the patient had no drug abuse or illicit drug usage. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 041A21A expiry: UNKNOWN) dose was not reported, administered on 08-APR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 10-APR-2021, the subject experienced shortness of breath. On 10-APR-2021, the subject experienced headache. On 10-APR-2021, the subject experienced tiredness. On 10-JUN-2021, the subject experienced swelling in both calves. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from headache, shortness of breath, tiredness, and swelling in both calves. This report was non-serious. This case, from the same reporter is linked to 20210800565.
Site: Pain at Injection Site-Medium, Additional Details: patient stated stiffness and pain in the arm, saw md who stated monitor and that will go away over time.  I recommended Ibuprofen for a few days and follow back up with md if not improving over time.  as of June 19, 2021 there was still stiffness but was getting better
Peroneal nerve neuropathy with foot drop, this is now resolving but not completely gone.
Developed a baseball size red area at insertion site 13 days after receiving injection. It is not raised or sore. It is hot to touch.  Does not itch.  No treatment has been completed at this time.
At 10 pm after receiving the injection, pain developed and worsened as night continued to a severe level through to a.m. of next day. The pain radiated down the arm to hand. I was unable to move that arm independently both due to the lameness of the limb and severe pain level when moved by my other hand. 2 Tylenol extra strength were taken at 11pm when pain was developing; 2 more were taken at 4a.m.; 2 more at 9am of Feb 26th. The Tylenol helped alleviate some of the pain, but it was still at a level 8 out of 10 and unable to move it. Pain in the arm receded to about a level 4 Feb 27. Minor soreness was present Feb 28 but functional with 1 Tylenol. No pain March 1 March 2 some pain returned; manageble with 1 Tylenol. March 4 pain and soreness returned to about a level 5 and took 1 Tylenol.
pt recvd vax 1FEB94 & 2FEB94 started vomiting @ about 730PM on 1FEB93 was still vomiting; per mom pt had been unable to keep anything down; mom states pt felt warm; pt slept twice for 1 hr each & was clingy; also diarrhea; seen by MD;
pallid spell-limp, pale, difficult to arouse, grunting, nasal flaring, salivary bubbling @ the mouth;intermittent cough;adm to hosp r/o aspiration pneumonia secondary GERD;
myocarditis; pericarditis; hard time breathing; he felt toasty and warm; chills; cold; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 22 year-old male patient received bnt162b2 (COMIRNATY), administration date May2021 (Batch/Lot number: unknown) at the age of 22 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: MYOCARDITIS (medically significant) with onset 2021, outcome "unknown", described as "myocarditis"; PERICARDITIS (medically significant) with onset 2021, outcome "unknown", described as "pericarditis"; DYSPNOEA (non-serious) with onset 2021, outcome "unknown", described as "hard time breathing"; FEELING HOT (non-serious) with onset 2021, outcome "unknown", described as "he felt toasty and warm"; CHILLS (non-serious) with onset 2021, outcome "unknown", described as "chills"; FEELING COLD (non-serious) with onset 2021, outcome "unknown", described as "cold". The patient underwent the following laboratory tests and procedures: body temperature: unknown results.  Additional Information: The patient received the first dose of the purple cap Pfizer Covid-19 vaccine back in May2021 when he was 21 years-old.  He reports that him and his mom got the first dose at the same time.  He also reported that he had a pain in his heart.  He denies having a reaction to the second dose of the Pfizer Covid-19 vaccine.  He is asking the following: if he should get the booster dose of the purple cap Pfizer Covid-19 vaccine after experiencing what he did with the first dose.  What information is there on the cardiac symptoms that he felt with the Pfizer Covid-19 vaccine. What are the side effects of the booster dose of the purple cap Pfizer Covid-19 vaccine.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Patient reported on 11/15/19: Patient stated that her arm became red and was swollen and hot/warm, it was red from the site of injection to the inside of her elbow, the red area was wide, it was tingling, it started to itch, the reaction lasted about 7 days. Patient also stated that she had no fever and no nausea.
sore; redness; itchhing; A spontaneous report was received from a consumer concerning a 31-year-old, male patient, who received Moderna's COVID-19 vaccine (mRNA-1273)  experienced sore, itching, redness 3 inches in diameter that went away and came back on the 9th day.  The patient's medical history was not reported. Concomitant medication Ajovy,Botox  were reported for drug use for unknown indication.  On 13-jan-2021 prior to the onset of the events, the patient received her first of two planned doses of mRNA-1273 (Lot number: 012L20A) for prophylaxis of COVID-19 infection.    On an unknown date patient experienced sore, itching, redness 3 inches in diameter that went away and came back on the 9th day.   The patient was treated for the event with ibuprofen and prednisone.  The action taken for Moderna COVID-19 Vaccine was not reported.     At the time of this report, the outcome of the events redness,sore and itching is Unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Vaccines that were administered beyond use date after thaw process; This spontaneous case was reported by a paramedic and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccines that were administered beyond use date after thaw process) in a 27-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027H21B) for COVID-19 prophylaxis. No Medical History information was reported. On 28-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 milliliter. On 28-Dec-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccines that were administered beyond use date after thaw process). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccines that were administered beyond use date after thaw process) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Patient age was reported as 27 years 10 months. No concomitant medication was reported. It was reported that vaccine was administered beyond use date to the patients. There was no adverse reaction noted or reported regarding these administrations. Vaccine NDC code. No treatment medication was reported.
Described not feeling 'right.'Breathing off. Sats remained 99-100%. Pulse 76-88 then approximately 20 minutes after vaccine administered stated feeling shaky. Noted to be diaphoretic with diluted pupils, pulse dropped to 38-46 range. Never lost consciousness. Responding appropriately. 911 called. Refused transport to hospital multiple times. After monitoring for about 1 hour and drinking a bottle of water, stated felt better but still not right. Drove self home. Stated had appointment already scheduled with PCP next morning for a physical. Stated someone would be at home that could check on him. Refused anything to eat.
Left neck, jaw, and tooth pain and numbness that began about 15 minutes after injection and lasted 1-2 hours
Systemic: Allergic: Difficulty Swallowing, Throat Tightness-Severe, Systemic: Allergic: Swelling of Face / Eyes / Mouth / Tongue-Medium, Systemic: Dizziness / Lightheadness-Medium, Systemic: Headache-Mild, Additional Details: pt began having symptoms 30-45 min after injection of 2 nd dose, ambulance summoned and pt taken to er
Pt. husband states pt. has shortness of breath, aching, symptoms onset next day.
About 3 weeks after first dose of vaccine, began to experience eye issues. Intense photophobia, dry eye syndrome, general eye pain, bilateral uveitis (both eyes), fatigue, neurological issues, memory issues. Consulted with several specialists and have not figured out what is going on, they believe I may have a vestibular migraine complex. Since starting migraine treatment. Currently taking gabapentin, cannot take psychiatric medications with the dry eye. 1x/month injectable for migraines (ajovie). 5 mg valium as needed for dizziness. Have a cycle of extreme exertion and then symptoms flare up, recently having some heart issues and peripheral neuropathy.
extreme gut pain right behind my solar plexus. I had the shot on Saturday and Sunday morning I was in agony all day. It is Tuesday and it is still very much there
scar left from the rash; Itchy rash reoccurred; experienced muscle pain as well/Muscle pain reoccurred; Shortly after 2nd dose, rash on her left hand, left foot, right arm elbow and below stomach flared up; This spontaneous case was reported by a consumer and describes the occurrence of SCAR (scar left from the rash), RASH (Shortly after 2nd dose, rash on her left hand, left foot, right arm elbow and below stomach flared up), RASH PRURITIC (Itchy rash reoccurred) and MYALGIA (experienced muscle pain as well/Muscle pain reoccurred) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018B21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 (The doctors thought that the patient had COVID in Mar 2020. It was never formally diagnosed due to lack of staff that time.) in March 2020.   On 28-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 26-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-May-2021, the patient experienced RASH (Shortly after 2nd dose, rash on her left hand, left foot, right arm elbow and below stomach flared up). On an unknown date, the patient experienced SCAR (scar left from the rash), RASH PRURITIC (Itchy rash reoccurred) and MYALGIA (experienced muscle pain as well/Muscle pain reoccurred). The patient was treated with CORTISONE at an unspecified dose and frequency and VITAMIN E [VITAMIN E NOS] at an unspecified dose and frequency. At the time of the report, SCAR (scar left from the rash), RASH (Shortly after 2nd dose, rash on her left hand, left foot, right arm elbow and below stomach flared up), RASH PRURITIC (Itchy rash reoccurred) and MYALGIA (experienced muscle pain as well/Muscle pain reoccurred) had not resolved.            No concomitant medications were reported.  Patient had no allergic conditions. Patient had no history related to mentioned adverse event, acute and chronic illnesses at the time of vaccination. It was reported that the adverse events were worsening. No information provided on other vaccines given 1 month prior to Moderna COVID-19 vaccine. It was reported that one doctor thought that the events were eczema and another doctor thought that the patient had scabies. Patient stated that the rash not gone away and it was flaring up.  Patient also stated that other skin creams were also used as treatment.   This case was linked to MOD-2022-510160 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 11-Mar-2022: Follow-up received contains no new information.
Patient had severe rash over entire body including creases, the rash left scarring on the face, the rash started to appear approximately 2 days post injection
Patient reported numbness and tingling in all fingers shortly after injection, symptoms resolved within 30 min observation.
Onset of symptoms were 1 week post vaccination. She experienced swelling and redness at site and around the arm. She had one sided face swelling including what she said felt like hives inside her mouth.
Post vax, the pt developed a measles rash on trunk, extremities, and face.
Patient had loss consciousness (fainted) immediately after vaccine given while still in chair.   BP 84/58.  Was taken to observation area via wheelchair to be monitored.  She laid flat for 10 minutes then sat up.  She left without assistance.  BP 118/72  No known adverse reactions noted.
Shortly after receiving vaccine patient experienced a 'tickle in her throat' and a rash on her face. Approx. 1 hour after the vaccine she went to the ER complaining of difficulty swallowing, throat tightness, dyspnea and SOB
This spontaneous report was received from a medical assistant refers to a patient of unknown age and gender. The patient's pertinent medical history, allergic reactions and concomitant medications were unspecified. On 17-AUG-2016, the patient was vaccinated with an improperly stored dose of (Oka/Merck) VARIVAX (lot # M000996, expiry date 07-JAN-2018, dose, strength, vaccination site, route unspecified). The vaccine was exposed to a temperature of 6.5 Fahrenheit (F) for 80 hours. Digital data logger was not involved. There was no previous temperature excursions. No adverse effects were reported. Product quality complaint (PQC) was not involved. This is one of several reports received from the same reporter. Additional information has been requested.
3 days post = tremors; 4 days post= pneumonia; 6 days post= hospitalized